Imiquimod
- PDF / 140,791 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 19 Downloads / 130 Views
1
Imiquimod Chemical conjunctivitis in an elderly patient: case report In a retrospective study*, a 79-year-old man started receiving topical imiquimod five times weekly [dose not stated] for periocular intraepidermal squamous cell carcinoma. Skin irritation and chemical conjunctivitis subsequently developed [time to reaction onset not stated], and his dosage was reduced to twice weekly. Within 2 weeks, his conjunctivitis had resolved. * the authors described four other patients who receiving imiquimod for periocular tumours, but treatment was not associated with adverse drug reactions in these cases. Ross AH, et al. The use of imiquimod in the treatment of periocular tumours. Orbit 29: 83-87, No. 2, Apr 2010. Available from: URL: http:// 803027860 dx.doi.org/10.3109/01676830903294909 - United Kingdom
0114-9954/10/1314-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved
Reactions 14 Aug 2010 No. 1314
Data Loading...
